To our knowledge, this is the first description of possible genetic susceptibility factors influencing the risk of developing or avoiding the lung disease in AATD and possibly, by extension, in COPD with normal AAT levels. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.